Literature DB >> 2026458

Serum levels of tumor necrosis factor determine the fatal or non-fatal course of endotoxic shock.

T Mózes1, S Ben-Efraim, C J Tak, J P Heiligers, P R Saxena, I L Bonta.   

Abstract

The role of tumor necrosis factor alpha (TNF alpha) in endotoxin-induced shock was investigated in pigs receiving 5 micrograms kg-1 of Escherichia coli endotoxin (LPS) during 60 min of continuous infusion into the superior mesenteric artery. LPS concentration in aortic plasma, as determined by a chromogenic Limulus amoebocyte lysate (LAL) test, reached a peak of approximately 1000 ng l-1 during LPS infusion, and declined rapidly after discontinuation of the infusion. Serum TNF levels were determined by a bioassay using the L929 murine transformed fibroblast line. Eight of the 17 animals infused with LPS died within 30 min after beginning LPS administration, while the other 9 pigs survived beyond the experimental observation period of 3 h, although they were in a state of shock. No difference in LPS concentration was found between the survivors and the non-survivors. However, the serum TNF levels in non-survivors were significantly higher than in survivors when measured at 30 min after beginning LPS administration. In survivors, the peak increase in serum TNF levels was measured at 60 min after the beginning of LPS injection and returned rapidly to the baseline values. Although the role of TNF inducing rapid death seems to be dominant, the hemodynamic, hematology and blood chemistry disturbances seen during shock continued in survivors long after the return of TNF to baseline levels. These findings indicate that besides TNF other mediators are also involved in the LPS infusion-induced shock.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026458     DOI: 10.1016/0165-2478(91)90144-y

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  8 in total

1.  Strain-dependent activation of monocytes and inflammatory macrophages by lipopolysaccharide of Porphyromonas gingivalis.

Authors:  L Shapira; C Champagne; T E Van Dyke; S Amar
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  A synthetic lipopolysaccharide-binding peptide based on the neutrophil-derived protein CAP37 prevents endotoxin-induced responses in conscious rats.

Authors:  D J Brackett; M R Lerner; M A Lacquement; R He; H A Pereira
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion.

Authors:  L Shapira; W A Soskolne; Y Houri; V Barak; A Halabi; A Stabholz
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

4.  Modulation of alpha 1-acid glycoprotein (AGP) gene induction following honey bee venom administration to adjuvant arthritic (AA) rats; possible role of AGP on AA development.

Authors:  M Yiangou; C Konidaris; P Victoratos; L Hadjipetrou-Kourounakis
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

5.  Acute ethanol consumption synergizes with trauma to increase monocyte tumor necrosis factor alpha production late postinjury.

Authors:  G Szabo; P Mandrekar; B Verma; A Isaac; D Catalano
Journal:  J Clin Immunol       Date:  1994-11       Impact factor: 8.317

6.  Endotoxin and cytokines in patients with gastrointestinal tract perforation.

Authors:  S Endo; K Inada; Y Inoue; T Otsu; T Kasai; Y Kuwata; S Hoshi; M Yoshida
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

7.  LPS-induced serum TNF production and lethality in mice: effect of L-carnitine and some acyl-derivatives.

Authors:  V Ruggiero; C M D'Urso; C Albertoni; S Campo; P Foresta; E A Martelli
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

8.  Interactions between platelet activating factor and eicosanoids during endotoxic shock in anaesthetized pigs.

Authors:  T Mózes; F J Zijlstra; J P Heiligers
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.